Logo image of ALTRO.PA

TRONIC'S MICROSYSTEMS SA (ALTRO.PA) Stock Fundamental Analysis

EPA:ALTRO - Euronext Paris - Matif - FR0004175099 - Common Stock - Currency: EUR

3.64  -0.86 (-19.11%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALTRO. ALTRO was compared to 57 industry peers in the Semiconductors & Semiconductor Equipment industry. ALTRO has a bad profitability rating. Also its financial health evaluation is rather negative. ALTRO is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALTRO had positive earnings in the past year.
In the past year ALTRO had a positive cash flow from operations.
In the past 5 years ALTRO reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: ALTRO reported negative operating cash flow in multiple years.
ALTRO.PA Yearly Net Income VS EBIT VS OCF VS FCFALTRO.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

ALTRO has a Return On Assets of 9.13%. This is comparable to the rest of the industry: ALTRO outperforms 46.55% of its industry peers.
Industry RankSector Rank
ROA 9.13%
ROE N/A
ROIC N/A
ROA(3y)-13.96%
ROA(5y)-18.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALTRO.PA Yearly ROA, ROE, ROICALTRO.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K -1K

1.3 Margins

ALTRO's Profit Margin of 8.06% is on the low side compared to the rest of the industry. ALTRO is outperformed by 67.24% of its industry peers.
Looking at the Operating Margin, with a value of 11.45%, ALTRO is doing worse than 67.24% of the companies in the same industry.
Looking at the Gross Margin, with a value of 56.89%, ALTRO is in the better half of the industry, outperforming 79.31% of the companies in the same industry.
ALTRO's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.45%
PM (TTM) 8.06%
GM 56.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.02%
GM growth 5Y177.72%
ALTRO.PA Yearly Profit, Operating, Gross MarginsALTRO.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

2

2. Health

2.1 Basic Checks

ALTRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALTRO has about the same amount of shares outstanding.
ALTRO has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALTRO has been reduced compared to a year ago.
ALTRO.PA Yearly Shares OutstandingALTRO.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
ALTRO.PA Yearly Total Debt VS Total AssetsALTRO.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

ALTRO has an Altman-Z score of 0.15. This is a bad value and indicates that ALTRO is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.15, ALTRO is not doing good in the industry: 87.93% of the companies in the same industry are doing better.
ALTRO has a debt to FCF ratio of 3.16. This is a good value and a sign of high solvency as ALTRO would need 3.16 years to pay back of all of its debts.
ALTRO has a Debt to FCF ratio (3.16) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.16
Altman-Z 0.15
ROIC/WACCN/A
WACC10.31%
ALTRO.PA Yearly LT Debt VS Equity VS FCFALTRO.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

ALTRO has a Current Ratio of 0.43. This is a bad value and indicates that ALTRO is not financially healthy enough and could expect problems in meeting its short term obligations.
ALTRO has a Current ratio of 0.43. This is amonst the worse of the industry: ALTRO underperforms 94.83% of its industry peers.
ALTRO has a Quick Ratio of 0.43. This is a bad value and indicates that ALTRO is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.23, ALTRO is not doing good in the industry: 94.83% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.43
Quick Ratio 0.23
ALTRO.PA Yearly Current Assets VS Current LiabilitesALTRO.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

4

3. Growth

3.1 Past

ALTRO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 170.67%, which is quite impressive.
The Revenue has grown by 20.64% in the past year. This is a very strong growth!
The Revenue has been growing by 15.70% on average over the past years. This is quite good.
EPS 1Y (TTM)170.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%236%
Revenue 1Y (TTM)20.64%
Revenue growth 3Y16.25%
Revenue growth 5Y15.7%
Sales Q2Q%10.2%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALTRO.PA Yearly Revenue VS EstimatesALTRO.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALTRO.PA Yearly EPS VS EstimatesALTRO.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 28.00, ALTRO can be considered very expensive at the moment.
ALTRO's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of ALTRO to the average of the S&P500 Index (29.35), we can say ALTRO is valued inline with the index average.
Industry RankSector Rank
PE 28
Fwd PE N/A
ALTRO.PA Price Earnings VS Forward Price EarningsALTRO.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALTRO.
98.28% of the companies in the same industry are more expensive than ALTRO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.32
EV/EBITDA 16.39
ALTRO.PA Per share dataALTRO.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALTRO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TRONIC'S MICROSYSTEMS SA

EPA:ALTRO (3/6/2025, 7:00:00 PM)

3.64

-0.86 (-19.11%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap32.94M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 28
Fwd PE N/A
P/S 2.3
P/FCF 9.32
P/OCF 7.36
P/B N/A
P/tB N/A
EV/EBITDA 16.39
EPS(TTM)0.13
EY3.57%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.39
FCFY10.73%
OCF(TTM)0.49
OCFY13.58%
SpS1.59
BVpS-0.56
TBVpS-0.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.13%
ROE N/A
ROCE -33.89%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 11.45%
PM (TTM) 8.06%
GM 56.89%
FCFM 24.65%
ROA(3y)-13.96%
ROA(5y)-18.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y22.02%
GM growth 5Y177.72%
F-Score5
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.16
Debt/EBITDA 0.25
Cap/Depr 89.41%
Cap/Sales 6.53%
Interest Coverage 250
Cash Conversion 166.28%
Profit Quality 305.62%
Current Ratio 0.43
Quick Ratio 0.23
Altman-Z 0.15
F-Score5
WACC10.31%
ROIC/WACCN/A
Cap/Depr(3y)55.69%
Cap/Depr(5y)61.51%
Cap/Sales(3y)10.65%
Cap/Sales(5y)15.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)170.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%236%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)20.64%
Revenue growth 3Y16.25%
Revenue growth 5Y15.7%
Sales Q2Q%10.2%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-40.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y376.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2336.5%
OCF growth 3YN/A
OCF growth 5YN/A